Novel Spirooxindole–Benzofuran Scaffold: Potential Inhibition Against Hepatocellular Carcinoma by Targeting MDM2‐p53 Interaction DOI
Muhanna K. Al‐Muhanna, Assem Barakat, Mohammad Shahidul Islam

et al.

ChemistrySelect, Journal Year: 2024, Volume and Issue: 9(46)

Published: Dec. 1, 2024

Abstract We synthesized a novel compound library featuring spirooxindole core structure combined with various heterocycles, including benzofuran, benzothiophene, and thiophene scaffolds. Evaluation using MTT assays against HepG2, 4T1, MDA‐MB‐231 cells revealed the most potent candidate, hybrid 5c , an IC50 of 5 ± 0.6 µM inducing G2/M phase cell cycle arrest, inhibition wound healing, induction ROS. Selected conjugates exhibited significant inhibitory potential MDM2, KD values ranging from 0.0531 to 16.8 µM. Notably, salt analogue 5q demonstrated highest activity at K D = 53.1 nM. Molecular docking studies excellent accommodation designed compounds within MDM2 receptor. All displayed favorable ADME profiles, suggesting their as lead for further optimization.

Language: Английский

Visible-Light-Mediated O–H Functionalization Reactions of Acetylenic alcohols with 3-diazooxindoles: Facile Access to Spirooxindole-Fused Oxacycles DOI

Liqin Xu,

Jing Wang,

Hujin Li

et al.

Tetrahedron, Journal Year: 2024, Volume and Issue: 159, P. 134014 - 134014

Published: May 3, 2024

Language: Английский

Citations

2

Anticancer potential of spirooxindole derivatives DOI

Mohd Faiyyaz,

Akanksha Tiwari,

Saud Nusrat Ali

et al.

Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 605 - 619

Published: Jan. 1, 2024

Citations

2

A Perspective of the Amide Group Containing FDA Approved Anticancer Drugs from 2021–2022 (A Review) DOI
Mohd Asif,

Rohan Srivastava,

Alisha Fatima

et al.

Russian Journal of Bioorganic Chemistry, Journal Year: 2023, Volume and Issue: 49(6), P. 1165 - 1176

Published: Nov. 1, 2023

Language: Английский

Citations

6

Synthesis of highly functionalized imine-containing halogen-substituted-1-oxo-acenaphthenes and their quantum computational investigation as propitious drugs for anti-skin cancer DOI
Aslı Eşme, Abul Hasnat,

Nuzhat Bashir

et al.

Journal of Molecular Liquids, Journal Year: 2024, Volume and Issue: 415, P. 126402 - 126402

Published: Nov. 1, 2024

Language: Английский

Citations

1

Spirooxindole derivatives as an anticancer agents: Synthetic developments, structure–activity relationship, and biological applications DOI

Shivani,

Tanmoy Tantra,

Sandeep Chaudhary

et al.

Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 387 - 409

Published: Jan. 1, 2024

Language: Английский

Citations

0

COF‐SO3H‐Catalyzed Synthesis of Pyrazoline‐Pyridine Hybrids with Dual Antioxidant and Anti‐Inflammatory Activity Targeting PDE4B DOI
Nida Khan, Mohd Kamil Hussain, Mohammad Faheem Khan

et al.

Chemistry & Biodiversity, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 11, 2024

Abstract This study explores new anti‐inflammatory agents by synthesizing pyrazoline‐pyridine hybrids with N‐butylsulfonated covalent organic framework (COF‐SO 3 H) as a recyclable catalyst, achieving excellent yields in just one minute. The protocol was successfully scaled up to multi‐gram scale, highlighting its robustness and efficiency, it operates without the need for column chromatography. Among synthesized hybrids, compound 5d , hybrid bearing an indole moiety, emerged potent antioxidant agent. It effectively inhibited PDE4B activation IC 50 value of 99.38 nM, adversely affecting HEK cells. Compound demonstrated dual activity significantly reducing ROS production restoring mitochondrial health LPS‐stimulated A549 cells, while also downregulating IL‐1β NF‐ĸB/p65 expression In silico studies confirmed ’s strong binding PDE4B, stable RMSD RMSF values, indicating potential effective inhibitor. exhibited favorable physicochemical properties, met drug‐likeness criteria, showed low toxicity predicted silico. These findings suggest that has significant therapeutic agent inflammatory diseases due activities.

Language: Английский

Citations

0

Novel Spirooxindole–Benzofuran Scaffold: Potential Inhibition Against Hepatocellular Carcinoma by Targeting MDM2‐p53 Interaction DOI
Muhanna K. Al‐Muhanna, Assem Barakat, Mohammad Shahidul Islam

et al.

ChemistrySelect, Journal Year: 2024, Volume and Issue: 9(46)

Published: Dec. 1, 2024

Abstract We synthesized a novel compound library featuring spirooxindole core structure combined with various heterocycles, including benzofuran, benzothiophene, and thiophene scaffolds. Evaluation using MTT assays against HepG2, 4T1, MDA‐MB‐231 cells revealed the most potent candidate, hybrid 5c , an IC50 of 5 ± 0.6 µM inducing G2/M phase cell cycle arrest, inhibition wound healing, induction ROS. Selected conjugates exhibited significant inhibitory potential MDM2, KD values ranging from 0.0531 to 16.8 µM. Notably, salt analogue 5q demonstrated highest activity at K D = 53.1 nM. Molecular docking studies excellent accommodation designed compounds within MDM2 receptor. All displayed favorable ADME profiles, suggesting their as lead for further optimization.

Language: Английский

Citations

0